Medtronic, Bard Get Additional CMS Reimbursement

Monday, August 3, 2015

Source: FierceMedicalDevices

C.R. Bard ($BCR) and Medtronic ($MDT) announced that the federal Centers for Medicare & Medicaid Services has given them new technology add-on payments for their drug-coated angioplasty balloons to help hospitals cover the costs of treating patients with the device.

View All News »